Senior Health Channel
Topics & Medications
Quicklinks
Related Channels

Risedronate Delayed-Release Drug Information

Risedronate delayed-release (AtelviaTM) is approved for the treatment of osteoporosis in postmenopausal women. This medication is unique in that, unlike other bisphosphonates, you do not need to take it on an empty stomach. In fact, risedronate delayed-release is designed to be taken immediately after breakfast.
 
Prior to taking this medication, review the safety information for risedronate delayed-release with your healthcare provider. This drug is not suitable for everyone, in particular those with kidney disease or esophageal problems. In addition, drug interactions are possible, so your healthcare provider needs a complete list of all other medicines you are taking, including supplements.
 
(Click Risedronate Delayed-Release for more information, including how this drug works, general dosing guidelines, possible side effects, and what to do if you take too much.)
 

Risedronate Delayed-Release Drug Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.